Novo Nordisk A/S company logo
Novo Nordisk A/S logo

Novo Nordisk A/S (NVO) Depreciation & Amortization

Annual D&A

$3.32B$2.08B+168.24%

Summary

Current Value
As of today, NVO annual D&A is $3.32B, up +168.24% on
Historical Performance
NVO annual D&A is up +256.40% over the past 3 years, up +312.00% over the past 5 years
All-Time High Comparison
NVO annual D&A is currently at its all-time high
3-Year Low Comparison
NVO annual D&A is +256.40% above its 3-year low of $932.67M reached on an earlier date
Sector Comparison
NVO annual D&A is higher than 99.00% of companies in Healthcare sector

Depreciation & Amortization Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

NVO Performance
MetricDateValue1Y3Y5Y15Y
Annual D&A$3.32B+168.2%+256.4%+312.0%+679.8%
Quarterly D&A$857.09M+209.9%+411.4%+476.2%+688.2%
TTM D&A$3.34B+167.4%+257.8%+313.6%+682.9%
Price$48.45-41.9%-31.6%+30.8%+283.6%
Annual SG&A$0.00-100.0%-100.0%-100.0%-100.0%
Annual Total Expenses$31.25B+13.8%+82.2%+140.9%+279.2%
Annual Operating Expenses$18.50B+22.5%+83.0%+143.3%+244.4%
Annual Revenue$46.74B+11.0%+87.0%+140.8%+332.8%

Depreciation & Amortization Highs

NVO Annual D&A Highs Comparison
PeriodHighDateCurrent
3Y$3.32Bat high
5Y$3.32Bat high
All$3.32Bat high

Depreciation & Amortization Lows

NVO Annual D&A Lows Comparison
PeriodLowDateCurrent
3Y$932.67MN/A+256.4%
5Y$806.82MN/A+312.0%
All$11.11M>+9999.0%

Depreciation & Amortization History

YearValueChange
$3.32B+168.2%
$1.24B+6.8%
$1.16B+24.4%
$932.67M+10.5%
$844.09M+4.6%
$806.82M+15.0%
$701.43M+16.3%
$602.90M+38.5%
$435.19M-4.5%
$455.69M+3.6%
$439.92M-11.6%
$497.52M+5.3%
$472.63M+6.5%
$443.99M-4.5%
$464.79M+9.0%
$426.27M-0.9%
$430.23M-1.7%
$437.65M+14.9%
$381.03M+15.4%
$330.33M+12.7%
$293.19M+12.1%
$261.50M+16.8%
$223.88M+44.1%
YearValueChange
$155.33M+19.7%
$129.77M+1.2%
$128.24M-36.8%
$202.93M-6.7%
$217.51M+26.1%
$172.43M-6.1%
$183.69M-9.8%
$203.56M+22.6%
$166.02M+35.1%
$122.87M+6.6%
$115.32M+24.8%
$92.37M+9.7%
$84.16M+30.4%
$64.52M+34.6%
$47.93M+24.0%
$38.67M+39.1%
$27.80M+47.9%
$18.79M+17.9%
$15.93M+10.1%
$14.48M+17.5%
$12.32M+10.9%
$11.11M-5.6%
$11.78M-

FAQ

  • What is the current annual D&A of NVO?

    As of today, NVO annual D&A is $3.32B

  • What is 1-year change in NVO annual D&A?

    NVO annual D&A is up +168.24% year-over-year

  • What is 3-year change in NVO annual D&A?

    NVO annual D&A is up +256.40% over the past 3 years

  • How far is NVO annual D&A from its all-time high?

    NVO annual D&A is currently at its all-time high

  • How does NVO annual D&A rank versus sector peers?

    NVO annual D&A is higher than 99.00% of companies in Healthcare sector

  • When is NVO next annual earnings release?

    As of today, the next annual earnings release for NVO has not been scheduled

Data Sources & References

  1. NVO Official Website www.novonordisk.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/353278/000035327826000012/0000353278-26-000012-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/353278/000035327826000012/0000353278-26-000012-index.htm
  4. NVO Profile on Yahoo Finance finance.yahoo.com/quote/NVO
  5. NVO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nvo